These theoretical findings are supported by the fact that cancer cells express a specific phosphatase (TIGAR) that catalyzes the degradation of the glycolytic activator Fru26P2 in order to suppress glycolysis and to redirect the glucose flux through the oxidative pentose phosphate pathway. The gene discussed is TIGAR; the disease is cancer.